June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Stephen Liu: Proud to be Part of the Team Behind the Phase III IMforte trial
Jun 5, 2025, 01:46

Stephen Liu: Proud to be Part of the Team Behind the Phase III IMforte trial

Stephen Liu, Associate Professor of Medicine at Georgetown University, posted on LinkedIn:

“Proud to be part of the team behind the phase III IMforte trial. This is the first phase 3 maintenance study in SCLC to show a survival benefit with an OS HR 0.73 – small cell lung cancer is an unforgiving disease and this strategy will allow patients to have a chance at extended survival.
Presentation at ASCO25 and simultaneous publication in the Lancet. Thanks to the whole team that helped make this happen.”

Title: Efficacy and safety of first-line maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small-cell lung cancer (IMforte): a randomised, multicentre, open-label, phase 3 trial

Authors: Luis Paz-Ares, Hossein Borghaei, Stephen V Liu, Solange Peters, Roy S Herbst, Katarzyna Stencel, Margarita Majem, Mehmet Ali Nahit Şendur, Grzegorz Czyżewicz, Reyes Bernabé Caro, Ki Hyeong Lee, Melissa L Johnson, Nuri Karadurmuş, Christian Grohé, Sofia Baka, Tibor Csőszi, Jin Seok Ahn, Raffaele Califano, Tsung-Ying Yang, Yasemin Kemal, Marcus Ballinger, Vaikunth Cuchelkar, Vilma Graupner, Ya-Chen Lin, Debasis Chakrabarti, Kamalnayan Bhatt, George Cai, Robert Iannone, Martin Reck

Read The Full Article at The Lancet.

Stephen Liu: Proud to be Part of the Team Behind the Phase III IMforte trial

More posts featuring Stephen V Liu.